SAHPRA grants approval to begin trial of PaxMedica’s long Covid-19 therapy
The trial will assess the tolerability, safety, efficacy and PK of two varying doses of suramin in adult LCS patients.
Middle East and Africa
Latest in
Middle East and Africa
The Middle East has seen the largest growth in infectious disease related trials over the past decade
We've analysed 10 years' worth of clinical trials data from GlobalData to pick out key geographic trends.
By
The Omicron variant – another reason to support equitable global vaccination coverage
The gaping inequity in global vaccination rates only ensures that new Covid-19 variants such as Omicron will continue to emerge.
By
J&J’s Covid-19 booster shot offers greater antibody responses
J&J’s booster given after Pfizer-BioNTech’s two-dose regimen led to a continued rise of antibodies for a minimum of four weeks.
Middle-income countries’ healthcare sectors to keep rising through to 2024
Healthcare provision markets of middle-income countries are set to climb at an average annual rate of 5.7% in the next…
By
WHO-approved malaria vaccine cuts childhood hospitalisation by 70%
The WHO’s approval of a malaria vaccine marks a public health milestone and signals renewed prospects for controlling the disease.
By
Asia-Pacific has seen the largest growth in gastrointestinal related trials over the past decade
We've analysed 10 years' worth of clinical trials data from GlobalData to pick out key geographic trends.
By
Vaxine to file for Australian approval of protein subunit Covid-19 vaccine
An Iran-staged trial shows SpikoGen exceeded the 60% efficacy bar in the primary endpoint of prevention of symptomatic disease.
By